BlackRock Health Sciences Term Trust to Repurchase Shares Amid 11% Discount
Event summary
- BlackRock Health Sciences Term Trust (BMEZ) will repurchase up to 5% of its outstanding shares at 98% of NAV due to an average 11.05% discount during the 9-month measurement period ending September 30, 2026.
- Tender offer commences October 16, 2026, and expires November 18, 2026, unless extended.
- No other BlackRock closed-end funds triggered repurchase offers under their discount management programs.
- BMEZ's board authorized the tender offer following a 'Trigger Event' during the measurement period.
The big picture
BlackRock's discount management programs aim to enhance shareholder value by repurchasing shares at a discount, a strategy increasingly common among asset managers facing persistent NAV discounts. The move reflects broader industry trends toward active governance of closed-end funds to align share prices with underlying asset values. With $XX billion in AUM across its closed-end funds, BlackRock's approach could set a precedent for how other managers handle discount pressures in volatile markets.
What we're watching
- Discount Management
- Whether BlackRock's discount management programs will effectively narrow the gap between share prices and NAV for other funds trading at significant discounts.
- Market Liquidity
- The impact of BMEZ's tender offer on market liquidity and shareholder participation.
- Regulatory Compliance
- How the SEC's oversight of tender offers may influence the timing and execution of similar programs across BlackRock's closed-end funds.